Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].

× No keyword cloud information.

12 in total

1. The fluorimetric estimation of catecholamines.

Authors: H WEIL-MALHERBE
Journal: Methods Med Res Date: 1961

2. DISTRIBUTION OF HOMOVANILLIC ACID IN THE HUMAN BRAIN.

Authors: H BERNHEIMER
Journal: Nature Date: 1964-11-07 Impact factor: 49.962

3. Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry.

Authors: T L SOURKES; G F MURPHY
Journal: Methods Med Res Date: 1961

4. Determination by thin-layer chromatography of urinary homovanillic acid in normal and disease states.

Authors: I SANKOFF; T L SOURKES
Journal: Can J Biochem Physiol Date: 1963-06

5. Dopamine metabolism in Parkinson's disease.

Authors: M GREER; C M WILLIAMS
Journal: Neurology Date: 1963-01 Impact factor: 9.910

6. [Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors].

Authors: H BERNHEIMER; W BIRKMAYER; O HORNYKIEWICZ
Journal: Wien Klin Wochenschr Date: 1962-08-17 Impact factor: 1.704

7. Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine.

Authors: A CARLSSON; N A HILLARP
Journal: Acta Physiol Scand Date: 1962-05

8. A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue.

Authors: D F SHARMAN
Journal: Br J Pharmacol Chemother Date: 1963-02

9. [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].

Authors: O HORNYKIEWICZ
Journal: Wien Klin Wochenschr Date: 1963-05-03 Impact factor: 1.704

10. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors: H EHRINGER; O HORNYKIEWICZ
Journal: Klin Wochenschr Date: 1960-12-15

20 in total

1. Dopaminergic reward system: a short integrative review.

Authors: Oscar Arias-Carrión; Maria Stamelou; Eric Murillo-Rodríguez; Manuel Menéndez-González; Ernst Pöppel
Journal: Int Arch Med Date: 2010-10-06

2. Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease.

Authors: F C Cheng; J S Kuo; L G Chia; G Dryhurst
Journal: J Neural Transm (Vienna) Date: 1996 Impact factor: 3.575

3. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.

Authors: Dae-Hee Lee; Cuk-Seong Kim; Yong J Lee
Journal: Food Chem Toxicol Date: 2010-11-05 Impact factor: 6.023

Review 4. Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.

Authors: Stephen J Kish; Isabelle Boileau; Russell C Callaghan; Junchao Tong
Journal: Eur J Neurosci Date: 2016-09-05 Impact factor: 3.386

5. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.

Authors: V P Barkhatova; E I Kandel'; E G Demina
Journal: Neurosci Behav Physiol Date: 1985 Mar-Apr

Review 6. Release from brain tissue of compounds with possible transmitter function: interaction of drugs with these substances.

Authors: M Vogt
Journal: Br J Pharmacol Date: 1969-10 Impact factor: 8.739

10. The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954.

Authors: D M Coward; N S Doggett
Journal: Psychopharmacology (Berl) Date: 1977-04-29 Impact factor: 4.530

[Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].